![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Abbvie Inc. North Chicago Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Biperiden hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R2-CEP 1995-038 - Rev 05
This Chemical Type CEP, issued on January 24, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1074 associated with this CEP further emphasizes